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Background: Fibrotic remodeling of airway and lung parenchymal compartments is attributed to pulmonary
dysfunction with an involvement of reactive oxygen species (ROS) in chronic lung diseases such as idiopathic
pulmonary fibrosis and asthma.
Methods: The in vitro study elucidated inhibitory effects of astragalin, kaempferol-3-O-glucoside from leaves of
persimmon and green tea seeds, on oxidative stress-induced airway fibrosis. The in vivo study explored the demoting
effects of astragalin on epithelial to mesenchymal transition in BALB/c mice sensitized with ovalbumin (OVA).
Results: The exposure of 20 μM H2O2 for 72 h accelerated E-cadherin loss and vimentin induction in airway epithelial
BEAS-2B cells, which was reversed by non-toxic astragalin at 1–20 μM. Astragalin allayed the airway tissue levels of ROS
and vimentin enhanced by OVA challenge. Collagen type 1 production increased in H2O2–exposed epithelial cells and
collagen fiber deposition was observed in OVA-challenged mouse airways. This study further investigated that
the oxidative stress-triggered autophagic regulation was responsible for inducing airway fibrosis. H2O2 highly
enhanced the expression induction of the autophagy-related beclin-1 and light chains 3A/B (LC3A/B) within 4 h
and astragalin blocked such induction by H2O2. This compound deterred the ROS-promoted autophagosome
formation in BEAS-2B cells. Consistently, in OVA-sensitized mice the expression of beclin-1 and LC3A/B was
highly induced, and oral administration of astragalin suppressed the autophagosome formation with inhibiting
the induction of these proteins in OVA-challenged airway subepithelium. Induction of autophagy by spermidine
influenced the epithelial induction of E-cadherin and vimentin that was blocked by treating astragalin.
Conclusion: These results demonstrate that astragalin can be effective in allaying ROS-promoted bronchial
fibrosis through inhibiting autophagosome formation in airways.
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Autophagy, a catabolic process, plays a role in the
elimination of damaged organelles and protein aggre-
gates and in the turnover of essential proteins [1,2].
This process is activated by a diverse array of cellular
stressors such as endoplasmic reticulum (ER) stress
and microbial infection [3,4]. Especially, the autopha-
gic pathways are modulated by oxidative stress re-
sponse to oxygen tension and oxidant [5]. There is an
emerging body of evidence that autophagy regulates
various cellular processes and cell fates, including cel-
lular death and senescence, inflammation and immune* Correspondence: yhkang@hallym.ac.kr
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unless otherwise stated.function [6]. In addition, maladaptive or pathogenic
aftereffects such as aberrant accumulation of proteins
are observed. Accordingly, impaired autophagy has
been implicated in many pathological conditions of
neurological disorders, inflammatory bowel disease,
diabetes and cancer [7]. Targeting autophagic pathways
and their regulatory components may lead to the de-
velopment of therapeutics.
Some environmental factors such as air pollutants
may cause an extreme increase of reactive oxygen spe-
cies (ROS) generation in the airways [8]. Oxidative
stress contributes to airway and lung damage and con-
sequently to several respiratory inflammatory diseases,
including cystic fibrosis and chronic obstructive pul-
monary disease [9]. Also, excessive production of ROSis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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asthma, where exhaled levels of ROS positively correl-
ate with disease severity [10]. Recent investigation has
shown a crucial involvement of autophagy in the patho-
genic processes underlying pulmonary diseases [11]. In-
deed, autophagy is observed in the lung in response to
oxidative stress evoked by the exposure to environmen-
tal toxicants [7,11]. Thus, the role of autophagy in
pulmonary toxicity may offer new clues to strategies to
treat lung injury linked to oxidative stress [12]. How-
ever, whether autophagy is responsible for promoting
cell survival or cytotoxicity in the airways and lung re-
mains elusive. In addition, the function of autophagy in
the disease pathogenesis is still unclear and may entail
impaired or elevated autophagic activity or imbalances
in the activation of autophagic proteins.
Asthma is associated with a cytokine milieu that pro-
motes transforming growth factor-β1 (TGF-β1)-affili-
ated airway remodeling and loss of lung function [10].
TGF-β1, a pleiotropic cytokine that has been estab-
lished as a central mediator of tissue fibrosis, regulatesFigure 1 Chemical structure of astragalin (A), cytoprotection of astragalin
in the bronchoalveolar lavage fluid (C, BALF). BEAS-2B cells were cultured w
for 72 h (B) and cell viability (mean ± SEM, n = 4) was measured by MTT a
after the final challenge with OVA or PBS vehicle (C). The bar graphs repres
P < 0.05.autophagy and manipulates many critical aspects of
disease-conditions associated with fibrosis and injury
responses [13]. Hence, understanding the cellular mech-
anism of TGF-β1-related autophagic process is crucial
for identifying potential new therapeutic targets. On the
other hand, a recent report indicates that fibroblasts in
idiopathic pulmonary fibrosis acquire resistance to apop-
tosis and autophagy [14]. Autophagy inhibition induces
acceleration of epithelial cell senescence and myofibro-
blast differentiation of lung fibroblasts which is an
underlying mechanism of the pathogenesis of idiopathic
pulmonary fibrosis [15].
Astragalin (Figure 1A), kaempferol-3-O-glucoside from
leaves of persimmon and green tea seeds, possesses
antiinflammatory activity [16,17]. One investigation
reveals that pretreatment with astragalin can improve
survival during lethal endotoxemia and attenuate inflam-
matory responses in a murine model of lipopolysaccharide
(LPS)-induced acute lung injury [17]. Our recent study
showed that astragalin antagonized endotoxin-induced
oxidative stress leading to epithelial eosinophilia andagainst H2O2 (B), and number of neutrophils, eosinophils and basophils
ith 20 μM H2O2 in the absence and presence of 1–20 μM astragalin
ssay. BALF was harvested from BALB/c mice (n = 6, each group) 24 h
ent quantitative results and means without a common letter differ,
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galin on pulmonary fibrosis and autophagy are not yet
elucidated. Based on the literature evidence that astra-
galin possesses antioxidant property and anti-allergic
activity [17,18], the current study investigated whether
astragalin inhibited epithelial to mesenchymal transi-
tion (EMT) leading to pulmonary fibrosis and autopha-
gic activity of H2O2-exposed airway epithelial BEAS-2B
cells and in ovalbumin (OVA)-challenged mice. Further-
more, the interconnection between pulmonary fibrosis
and autophagy under oxidative episodes was explored to




M199, human epidermal growth factor (EGF), hydro-
cortisone, gelatin, human insulin, apotransferrin and
H2O2 were obtained from the Sigma-Aldrich Chemical
(St. Louis, MO), as were all other reagents, unless
specifically stated elsewhere. Fetal bovine serum (FBS),
penicillin-streptomycin and trypsin-EDTA were pur-
chased from the Lonza (Walkersville, MD). The human
bronchial airway epithelial cell line BEAS-2B cells were
provided by the American Type Culture Collection
(Manassas, VA). Chicken egg white albumin was pur-
chased from the Sigma-Aldrich Chemical and Imject
Alum obtained from the Thermo Fisher Scienctific
(Rodkford, IL). Human collagen type-1 antibody was
purchased from the Santa Cruz Biotechnology (Santa
Cruz, CA). Human E-cadherin antibody was provided
by Cell Signaling Technology (Beverly, MA). Antibodies
of human beclin-1 and microtubule-associated protein
1 light chain 3A/B (LC3A/B) were obtained from
Abcam (Cambridge, UK). Horseradish peroxidase-
conjugated goat anti-rabbit IgG, donkey anti-goat IgG
and goat anti-mouse IgG were purchased from Jackson
Immuno-Research Laboratories (West Grove, PA). Al-
bumin from bovine serum (essentially fatty acid free-
BSA) and skim milk were supplied by Becton Dickinson
Company (Sparks, MD). 4′,6-Diamidino-2-phenylindole
(DAPI) was obtained from Santa Cruz Biotechnology
and monodansylcadaverine (MDC) was purchased from
Sigma-Aldrich Chemical. Astragalin was dissolved in
dimethyl sulfoxide (DMSO) for live culture with cells; a
final culture concentration of DMSO was <0.5%.
BEAS-2B cell culture and viability
The human lung epithelial BEAS-2B cells were cul-
tured in 25 mM HEPES-buffered M199 containing 10%
FBS, 2 mM L-glutamine, 100U/ml penicillin, 100 μg/
ml streptomycin supplemented with 2.5 μg/ml insulin,
361 ng/ml hydrocortisone, 2.5 μg/ml apotransferrin
and 20 ng/ml EGF. BEAS-2B cells were sustained in90-95% confluence at 37°C in an atmosphere of 5%
CO2. In order to induce airway fibrosis, BEAS-2B cells
were pretreated with 1–20 μM astragalin and then
stimulated with 20 μM H2O2 for up to 72 h. Non-
H2O2-treated cells were also incubated under the same
conditions as those used for the H2O2 protocols.
Astragalin did not improve the epithelial injury due to
20 μM H2O2 (Figure 1B).
Western blot analysis
Whole BEAS-2B cell lysates were prepared in 1 mM
Tris–HCl (pH 6.8) lysis buffer containing 10% SDS, 1%
glycerophosphate, 0.1 mM Na3VO4, 0.5 mM NaF and
protease inhibitor cocktail. Cell lysates containing
equal amounts of proteins and equal volume of culture
media were electrophoresed on 6-15% SDS-PAGE and
transferred onto a nitrocellulose membrane. Blocking a
non-specific binding was performed using either 3%
fatty acid-free BSA or 5% non-fat dry milk for 3 h. The
membrane was incubated overnight at 4°C with a spe-
cific primary antibody of E-cadherin, vimentin, collagen
type-1, beclin-1 and LC3A/B. The membrane was then
applied to a secondary antibody conjugated to horse-
radish peroxidase for 1 h. Following another triple
washing, the target protein was determined using the
Immobilon Western Chemiluminescent HRP Substrate
(Millipore Corp., Billerica, MA) and the Agfa medical
X-ray film blue (Agfa HealthCare NV, Mortsel,
Belgium). Incubation with mouse anti-human β-actin
antibody was conducted for the comparative control.
Murine asthma models
Six week-old male BALB/c mice (Hallym University
Breeding Center for Laboratory Animals) were used in
the present study. Mice were kept on a 12 h light/12 h
dark cycle at 23 ± 1°C with 50 ± 10% relative humidity
under specific pathogen-free conditions, fed a non-
purified diet (RodFeedTM, DBL, Umsung, Korea) and
were provided with water ad libitum at the animal facil-
ity of Hallym University. The non-purified diet compos-
ition is as follows: NLT (Not Less Than) 20.5% crude
protein, NLT 3.5% crude fat, NMT (Not More Than)
8.0% crude fiber, NMT 8.0% crude ash, NLT 0.5%
calcium and NLT 0.5% phosphorus. Mice were allowed
to acclimatize for 1 week before beginning the experi-
ments. Mice were divided into four subgroups (n = 6 for
each subgroup). Mice were sensitized with 20 μg OVA
dissolved in a solution of 30 μl PBS and 50 μl Imject
Alum by a subcutaneous injection twice on day 0 and
day 14. For the dietary interventions, 0.1 ml astragalin
solution (10 or 20 mg/kg BW) was orally administrated
to OVA-sensitized mice 1 h before challenge. On day
28, 29 and 30, 5% OVA inhalation to mice was per-
formed for 20 min in a plastic chamber linked to an
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Control mice were sensitized and challenged with PBS
as the OVA vehicle. Twenty four hours after the latest
provocation (day 30), all mice were killed with an
anesthetic (2 μl/kg rompun and 8 μl/kg zoletil, i.p.).
The trachea was cannulated, and both lungs and
airways were rinsed in 1 ml PBS for the collection of
bronchoalveolar lavage fluid (BALF). The numbers of
inflammatory cells including eosinophils in BALF were
determined using a Hemavet HV950 Multispecies
Hematologic Analyzer (Drew Scientific, Oxford, CT).
The right lungs were collected, frozen in liquid nitro-
gen and kept at −80°C until used for Western blotting.
Left lungs were preserved and fixed in 4% paraformal-
dehyde, and then used for immunohistochemical ana-
lyses. The total inflammatory cell number in the BALF
of mice exposed to OVA increased with a predomin-
ance of eosinophils (Figure 1C). The oral administra-
tion of astragalin deterred the increase in the number
of eosinophils in OVA-treated mice, indicating that
astragalin alleviated airway inflammation.
The present study was approved by the Hallym
University Institutional Review Board and Committee
on Animal Experimentation (hallym R2014-6). All
experiments were performed in compliance with the
University’s Guidelines for the Care and Use of Labora-
tory Animals. No mice were dead and no apparent
signs of exhaustion were observed during the experi-
mental period.
Measurement of ROS production
The lung tissue production of ROS was measured
using 2′-7′-dichlorofluorescein diacetate (DCF-DA)
that is hydrolyzed and oxidized by ROS to a fluorescent
compound 2′-7′-DCF. After lysation and incubation of
lung tissue extracts with DCF-DA for 30 min, the
fluorescence intensity was read in a Fluoroskan reader
(Thermo Fisher Scientific, Waltham, MA) with an
appropriate filter.
Immunohistochemical staining
For the immunofluorescent histochemical analysis,
paraffin-embedded lung tissue sections (5 μm thick-
ness) were deparaffinized and hydrated. The sections
were pre-incubated in a boiling sodium citrate buffer
(10 mM sodium citrate, 0.05% Tween 20, pH 6.0) for
antigen retrieval. The tissues were blocked with 5%
BSA in PBS for 1 h. Specific primary antibody against
mouse vimentin, mouse beclin-1, mouse LC3A/B or
mouse α-smooth muscle actin (α-SMA) was incubated
with the tissue sections overnight. Subsequently, the tissue
sections were incubated for 1 h with FITC-conjugated
anti-goat IgG or Cy3-conjugated anti-goat IgG. For
identification of nuclei, the fluorescent nucleic acid dyeDAPI was applied for 10 min. Stained tissues were
mounted on slides using fluorescent mounting medium
(Vector Laboratories, Burlingame, CA). Images of each
slide were taken using an optical microscope Axioima-
ger system (Zeiss, Gottingen, Germany).
Masson trichrome staining
For the histological analyses, lung specimens obtained
at the end of the experiments were fixed in 10% buff-
ered paraformaldehyde. The paraffin-embedded lung
specimen were sectioned at 5 μm thickness, deparaffi-
nized and stained with Masson trichrome for the light
microscopic visualization of collagen fibers and muscle
fibers. The stained tissue sections were examined using
an optical microscope system, and five images were
taken for each section.
MDC staining
Labeling of autophagic vacuoles was carried out by
using the autofluorescent compound MDC. BEAS-2B
cells were treated with 20 μM H2O2 to in the presence
of 1–20 μM astragalin for 4 h on a glass-chamber
slide and were incubated in MDC for 30 min. Follow-
ing the incubation, cells were washed three times with
PBS and immediately photographed with a fluores-
cence microscope.
The formation of autophagosomes in lung tissues was
measured by using lung specimen fixed in 10% buffered
paraformaldehyde. The paraffin-embedded lung tissue
sections were deparaffinized and stained with MDC for
the microscopic visualization. The fluorescent DAPI
was applied for the nuclear counterstaining.
Statistical analysis
The results were expressed as mean ± SEM for each
treatment group in each experiment. Statistical ana-
lyses were performed using Statistical Analysis Systems
statistical software package (SAS Institute, Cary, NC).
Significance was determined by one-way analysis of
variance, followed by Duncan range test for multiple
comparisons. Differences were considered significant at
P < 0.05.
Results
Inhibition of airway EMT and fibrosis by astragalin
The loss of the epithelial marker E-cadherin and the gain
of the mesenchymal marker vimentin are fundamental
events in EMT and important changes in the process of
fibrosis [19]. BEAS-2B cells exposed to 20 μM H2O2 up
to 72 h induced a change from epithelial phenotype to
mesenchymal (Figure 2A). The expression of E-cadherin
was reduced at 48 h following the H2O2 stimulation of
BEAS-2B cells. When 1–20 μM astragalin was added to
epithelial cells in the presence of H2O2, the cellular
Figure 2 Temporal response of E-cadherin loss (A), and inhibitory effects of astragalin on E-cadherin loss (B) and vimentin induction (C). After
cells were treated with 1–20 μM astragalin and stimulated with 20 μM H2O2 for up to 72 h, cell lysates were prepared for Western blotting with
a primary antibody against E-cadherin and vimentin. β-Actin protein was used as an internal control. The bar graphs (mean ± SEM, n = 3)
represent quantitative results of the upper bands obtained from a densitometer. Means without a common letter differ, P < 0.05.
Figure 3 Inhibition of ROS production (A) and vimentin induction (B and C) by oral administration of 10 mg/kg astragalin in OVA-challenged mouse
airway tissues. ROS production was measured by using the fluorescent stain DCF-DA and quantified at λ = 485 nm excitation and λ = 538 nm emission
(A). Tissue extracts were subject to Western blot analysis with anti-vimentin (B). The bar graphs (mean ± SEM, n = 3) represent quantitative results of
the upper bands obtained from a densitometer. Means without a common letter differ, P < 0.05. Vimentin identified as green staining was
visualized with a FITC-conjugated secondary antibody and nuclear staining was done with blue dye 4′,6-diamidino-2-phenylindole (C). Each
photograph is representative of four mice. Magnification: 200-fold.
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other hand, the 72 h stimulation of H2O2 markedly en-
hanced the epithelial expression of vimentin (Figure 2C).
When 1–20 μM astragalin was supplemented to H2O2-ex-
posed BEAS-2B cells, the vimentin induction was dose-
dependently downregulated. Accordingly, oxidative stress
may instigate EMT process and fibrosis in airways, which
can be disturbed by supplementing astragalin to the
epithelium.Figure 4 Suppressive effects of astragalin on collagen type-1 production
OVA-challenged mouse airways (B). BEAS-2B cells were cultured with 20 μ
Culture media were prepared for Western blotting with a primary antibo
represent quantitative results of the upper bands obtained from a densit
collagen fiber deposition in mouse airways was observed by Masson tric
quantified (bottom bar graphs, mean ± SEM). Each photograph is represeThis study attempted to determine whether asthmatic
injury triggered airway fibrosis, which was dampened by
the supplementation of astragalin. The OVA challenge
enhanced the ROS production in airway tissues and such
elevation was dose-dependently diminished by adminis-
trating 10–20 mg/kg astragalin (Figure 3A). Vimentin is
commonly used as a marker of cells of mesenchymal ori-
gin. Western blot analysis revealed that epithelial expres-
sion of vimentin typical in EMT was promoted by thein H2O2-exposed BEAS-2B cells (A) and collagen fiber deposition in
M H2O2 in the absence and presence of 1–20 μM astragalin for 72 h.
dy against collagen type-1 (A). The bar graphs (mean ± SEM, n = 3)
ometer. Means without a common letter differ, P < 0.05. Pathological
hrome staining (B). The collagen fibers were stained in blue and
ntative of four mice. Bar = 100 μm.
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tion of 20 mg/kg astragalin diminished the elevated induc-
tion of vimentin in airway tissues by the OVA episode. In
addition, the FITC-green staining of vimentin disappeared
in the airway epithelium of 20 mg/kg astragalin-exposed
mice (Figure 3C).
Subepithelial fibrosis in the airways entails the increased
deposition extracellular matrix (ECM) such as fibrogenic
collagen by myofibroblasts and submucosal resident fibro-
blasts and fibrocytes expressing profibrotic cytokines [20].
The epithelial production of collagen type-I was elevated in
BEAS-2B cells exposed to H2O2 and such production was
suppressed by adding ≥10 μM astragalin (Figure 4A). This
study further investigated that astragalin ameliorated the
structural remodeling of airways due to increased depos-
ition of ECM components. The collagen fiber deposition
was notably observed (blue color) in airway tissues of
OVA-challenged mice, evidenced by Masson’s trichromeFigure 5 Time course response of beclin-1 expression (A), and inhibition o
and in OVA-challenged mouse airways (C). BEAS-2B cells were cultured wit
up to 24 h. Cell lysates were prepared for Western blotting with a primary
internal control. The bar graphs (mean ± SEM, n = 3) represent quantitativ
without a common letter differ, P < 0.05. Immunofluorescence analysis showin
lung tissues (C). Beclin-1 indentified as red staining was visualized with a C
with 4′,6-diamidino-2-phenylindole. Each photograph is representative ofstaining (Figure 4B). There was a dense deposition of
collagen fibers around the bronchial tissues of OVA-
challenged mice. On the contrary, the oral treatment of
OVA-sensitized mice with 10–20 mg/kg astragalin re-
duced the collagen fiber deposition and alleviated sube-
pithelial fibrosis (Figure 4B). In addition, it should be
noted that the OVA sensitization induced epithelial cell
modulation and goblet cell hyperplasia (red color).
Blockade of airway autophagy by astragalin
When BEAS-2B cells were incubated with 20 μM H2O2
up to 24 h, epithelial expression of beclin-1 was strik-
ingly elevated at 4 h after H2O2 injury and thereafter
diminished (Figure 5A). However, its 4 h-epithelial in-
duction was encumbered by treating cells with ≥10 μM
astragalin (Figure 5B). Consistently, the OVA inhalation
to mice led to the increased levels of the autophagic
marker beclin-1 in mouse airway tissues, evidenced byf beclin-1 induction by astragalin in H2O2-stimulated BEAS-2B cells (B)
h 20 μM H2O2 in the absence and presence of 1–20 μM astragalin for
antibody against beclin-1 (A and B). β-Actin protein was used as an
e results of the upper bands obtained from a densitometer. Means
g inhibition of beclin-1 induction by astragalin in OVA-challenged mouse
y3-conjugated secondary antibody and nuclear staining was done
four mice. Magnification: 200-fold.
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administration of 20 mg/kg astragalin allayed the beclin-1
induction (loss of pinkish staining) in OVA-challenged
mouse airways. Microtubule-associated LC3A/B was highly
enhanced at 2–4 h after treating 20 μM H2O2 to BEAS-2B
cells (Figure 6A). The epithelial induction of LC3A/B by
H2O2 was diminished in ≥10 μM astragalin-treated BEAS-
2B cells exposed to H2O2 for 4 h (Figure 6B). Similarly,
Western blot data showed that the airway tissue levels of
LC3A/B increased in OVA-challenged mice, which was
dampened by supplementing ≥10 mg/kg astragalin to the
mice (Figure 6C).Figure 6 Time course responses of LC3A/B induction (A) and its inhibition b
mouse lung tissues (C). BEAS-2B cells were cultured with 20 μM H2O2 in
lysates (A and B) and OVA-challenged mouse lung tissue extracts (C) we
LC3A/B. β-Actin protein was used as an internal control. The bar graphs (
obtained from a densitometer. Means without a common letter differ, PAutophagy is characterized by the formation of double-
membrane autophagosomes that fuse with lysosomes to
form autolysosomes [21]. This study attempted to confirm
whether oxidative stress induced autophagosome forma-
tion in BEAS-2B cells. There was a strong MDC staining
observed in the cytoplasts of BEAS-2B cells exposed to 20
μM H2O2 (Figure 7A). When 1–20 μM astragalin was
added to the cells, dose-dependent decreases in the num-
ber of autophagosomes and in the MDC staining intensity
were observed (Figure 7A). Thus, astragalin may be an
antagonist to the autophagy induction of BEAS-2B cells in
response to H2O2. Autophagosome formation was furthery astragalin in H2O2-stimulated BEAS-2B cells (B) and in OVA-challenged
the absence and presence of 1–20 μM astragalin for up to 24 h. Cell
re prepared for Western blotting with a primary antibody against
mean ± SEM, n = 3) represent quantitative results of the upper bands
< 0.05.
Figure 7 Inhibition of epithelial formation of autophagic vacuoles by astragalin. BEAS-2B cells were cultured with 20 μM H2O2 in the absence and
presence of 1–20 μM astragalin for 4 h and incubated with monodansycadaverine (MDC) at 37°C for 10 min. MDC-loaded cells were visualized
by fluorescence microscopy and the fluorescent intensity was quantified (A). The bar graphs (mean ± SEM, n = 3) represent quantitative results
of the upper staining. Means without a common letter differ, P < 0.05. Immunofluorescence analysis showing inhibition of autophagosome formation
by astragalin in OVA-challenged mouse lung tissues (B). Autophagosomes indentified as green staining was visualized with MDC and nuclear staining
was done with 4′,6-diamidino-2-phenylindole. Each photograph is representative of four mice. Magnification: 200-fold.
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(Figure 7B). There was a strong MDC staining in cells
around the airway subepithelium of OVA-inhaled
mice. The autophagosomes were formed in similar
regions of airways to those of the collagen fiber depos-
ition (Figure 4B). When 10–20 mg/kg astragalin was
orally treated to OVA-sensitized mice, the MDC stain-
ing was highly diminished (Figure 7B).
Interconnection between airway fibrosis and autophagy
The epithelial induction of both α-SMA and LC3A/B
highly increased in airway subepithelium of OVA-
challenged mice (Figure 8A). Oral treatment of mice
with ≥10 mg/kg astragalin allayed the induction ofthese proteins by OVA challenge. It should be noted
that the induction of these proteins concurrently oc-
curred in similar regions of airway tissues. This study
attempted to reveal that epithelial autophagy might
be involved in the cellular alteration of airway EMT
process and fibrosis. Oxidative stress due to H2O2 caused
the induction of beclin-1 involved in the autophago-
some formation (Figures 5A and 8B). In addition, the
polyamine spermidine highly increased epithelial beclin-
1 induction regardless of H2O2 presence (Figure 8B).
The beclin-1 inducer promoted the vimentin induction
and the E-cadherin loss. Accordingly, epithelial autoph-
agy may be responsible for the EMT process in airways
leading to fibrosis.
Figure 8 Inhibition of autophagy and airway fibrosis by astragalin in OVA-challenged mouse airways (A) and autophagy-induced airway fibrosis
in H2O2-stimulated BEAS-2B cells (B). The induction of α-SMA and LC3A/B was evidenced by immunofluorescence analysis in OVA-challenged
mouse lung tissues (A). LC3A/B identified as green staining was visualized with a FITC-conjugated secondary antibody and α-SMA indentified as
red staining visualized with a Cy3-conjugated secondary antibody. Nuclear staining was done with 4′,6-diamidino-2-phenylindole. Each photograph is
representative of four mice. Magnification: 200-fold. After culturing cells with 20 μM H2O2 and/or 10 μM spermidine for 72 h, cell lysates were subject
to Western bolt analysis with a primary antibody against beclin-1, E-cadherin and vimentin (B). β-actin protein was used as an internal control. The bar
graphs (mean ± SEM, n = 3) in the bottom panel represent quantitative results of blots obtained from a densitometer. Means without a common letter
differ, P < 0.05.
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Eight major findings were extracted from this study.
1) Astragalin reduced the number of eosinophils in
the BALF of OVA-challenged BALB/c mice, indicat-
ing that its administration attenuated airway inflammation
entailing eosinophil infiltration in peribronchial and peri-
vascular airway. 2) BEAS-2B cells exposed to 20 μM H2O2
induced EMT process through reducing epithelial ex-
pression of E-cadherin and enhancing epithelial induc-
tion of vimentin. 3) When 1–20 μM astragalin was
added to epithelial cells in the presence of H2O2, the
cellular expression of E-cadherin was restored, but the
vimentin induction was dose-dependently attenuated. 4)
Oral administration of astragalin encumbered epithelialcell excrescence and thickening by diminishing the
vimentin induction and collagen fiber deposition in
OVA-challenged mouse airway. 5) H2O2 markedly pro-
moted epithelial induction of beclin-1 and LC3A/B
within 4 h with increasing the autophagosome forma-
tion, which was reversed by astragalin. 6) When ≥10
mg/kg astragalin was treated to OVA-challenged mice,
this compound suppressed the induction of beclin-1
and LC3A/B in airway tissues. 7) The protein induction
of vimentin, α-SMA and LC3A/B concurrently oc-
curred in similar regions of airway tissues of OVA-
inhaled mice. 8) The autophagy inducer promoted the
E-cadherin loss and enhanced the vimentin induction,
indicating that autophagy appeared to be responsible for
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in deterring airway EMT and fibrosis through modulat-
ing oxidative stress-responsive signaling pathway linked to
autophagy.
Oxidative stress causes airway and lung damage conse-
quently leading to several respiratory inflammatory dis-
eases such as chronic obstructive pulmonary disease
[9,10]. In addition, allergic asthma due to the exposure
to environmental antigens may entail an increase in
endogenous ROS formation, causing oxidative stress-
induced injury to the respiratory system and antioxidant
defenses [22,23]. In this study the ROS production was
highly induced in airway tissues of OVA-challenged
mice. Recent research suggests that the use of redox-
based therapy to attenuate levels of ROS provides a
potential strategy to alleviate oxidative stress-induced
airway inflammation in patients with asthma [22,24].
Therapeutic interventions that reduce the exposure to
environmental ROS or augment endogenous antioxidant
defenses might be beneficial as adjunctive therapies in
asthmatic patients [25]. Our recent study showed that
astragalin may be a potent antioxidant antagonizing
endotoxin-induced oxidative stress [18]. In addition,
astragalin blunted H2O2 -promoted epithelial apoptosis
concomitant with nuclear condensation or caspase-3 ac-
tivation. Currently, astragalin suppressed the airway in-
filtration of inflammatory cells following the exposure of
mice to the OVA antigen.
Although the specific mechanisms responsible for
chronic obstructive pulmonary diseases are still being
unraveled, ROS radicals are important mediators of air-
way tissue damage. Oxidative stress has been implicated
as an important molecular mechanism underlying fibro-
sis in the lungs [26]. However, the causal role of ROS
released from inflammatory/interstitial cells in mediating
fibrosis is not firmly established. Pulmonary fibrosis, a
progressive and lethal lung disease, is characterized by
inflammation and accumulation of ECM components
[27]. This study showed that the oxidant H2O2 enhanced
the collagen type-1 production and the OVA antigen
augmented the collagen fiber deposition in the airway
subepithelial compartments. Pulmonary fibrosis as well
as how best to relieve an imbalance in ROS production
would be major therapeutic challenges for which new
strategies are warranted. In the present study astragalin
as an antioxidant was effective in encumbering airway
fibrosis triggered by oxidative stress. Unfortunately, this
study did not examine the key origins of oxidative stress
in OVA-induced pulmonary fibrosis. Nevertheless, novel
insights into unique therapeutic targets of astragalin for
managing ROS-induced pulmonary fibrosis need to be
provided.
ROS and markers of oxidative stress play fundamental
roles in the pathology of idiopathic pulmonary fibrosischaracterized by interstitial fibrosis governing irrevers-
ible deformation of pulmonary architecture, possibly
through the induction of EMT [28]. One investigation
showed that the potent antioxidant N-acetylcysteine
inhibited TGF-β1-induced EMT in a rat epithelial cell
line and in primary rat alveolar epithelial cells, indicating
that oxidative stress might be responsible for pulmonary
function and the antioxidant possess its beneficial effects
on idiopathic pulmonary fibrosis [29]. In this study
astragalin allayed the EMT process by restoring E-
cadherin expression and reducing vimentin induction in
oxidant-experienced airway epithelial cells and OVA-
challenged airway tissues. There is growing evidence
suggesting that EMT entails TGF-β1 in alveolar epithe-
lial cells and may contribute to airway remodeling in se-
vere asthma and fibrotic lung diseases [10]. In addition,
the association between ROS and TGF-β1-induced fibro-
sis has been discussed [26]. Oxidative stress elicits the
production of cytokines and growth factors that may
play a pivotal role in invasive myofibroblastic differenti-
ation and collagen deposition. One can speculate that
astragalin alleviated oxidative stress and blocked TGF-β1
production, which might lead to the inhibition of airway
EMT and fibrosis.
A recent study shows that TGF-β1 regulates autoph-
agy involved in fibrosis of kidney diseases including
tubulointerstitial fibrosis, glomerulosclerosis, and dia-
betic nephropathy [13]. This study emphasized an emer-
ging role of the autophagy in pulmonary fibrosis. The
regulation of epithelial autophagy by TGF-β1 can be
implicated in the pathogenesis of asthmatic pulmonary
fibrosis. Oxidative stress has been shown to be involved
in the pathogenic process of autophagy [7,10,12]. In this
study the autophagic stress caused by H2O2 accelerated
the epithelial EMT, and the autophagic process concur-
rently occurred in airway fibrotic regions caused by
OVA inhalation in mice. A recent insight into the cellu-
lar and molecular bases of the autophagic process will
identify potential new therapeutic targets of pulmonary
fibrosis.
Autophagy is required for hepatic fibrogenesis by acti-
vated hepatic stellate cells in mice and selective reduction
of autophagic activity in fibrogenic cells might be used to
treat patients with fibrotic diseases [30]. Consistently, the
modulation of autophagy may have the potential to treat
common respiratory ailments and disorders. In this study
astragalin inhibited the autophagosome formation from
oxidant-exposed airway epithelial cells and in airway tis-
sues of OVA-inhaled mice through reducing the induction
of beclin-1 and LC3A/B. These findings indicate that oral
administration of astragalin may attenuate the oxidative
stress-induced autophagy and consequent fibrosis. On the
other hand, there are conflicting reports indicating that
fibroblasts in idiopathic pulmonary fibrosis are resistant to
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expression of autophagic beclin-1 [14,31]. The phenolic
compounds of rutin and curcumin function as a possible
effective stimulator of fatty acid-induced autophagy via
mTOR-dependent pathways in nonchemical induced-
hepatic stellate cells that can transdifferentiate into
myofibroblast-like cells, indicating their benefits for allevi-
ating liver fibrosis [32]. In addition, the autophagy inhib-
ition induces acceleration of epithelial cell senescence
[15]. Accordingly, whether autophagy is responsible for
promoting epithelial toxicity or survival in airways and
lung should be clarified. Ultimately, the unique role of
autophagy in pulmonary toxicity linked to oxidative stress
may provide novel clues to strategies to treat pulmonary
fibrosis [12].
Conclusion
This study investigated the potential of astragalin as a
modulator antagonizing oxidative stress-associated
autophagy leading to pulmonary fibrosis. Astragalin
restored the expression of the epithelial marker E-cadherin
and suppressed the H2O2 induction of the mesenchymal
vimentin in epithelial cells and in OVA-challenged
mouse airway tissues. Oral administration of astragalin
inhibited subepithelial deposition of collagen fibers in
OVA-sensitized mouse airways. In addition, astragalin
reduced the bronchial subepithelial induction of the
autophagic beclin-1 and LC3A/B enhanced by H2O2
oxidant and OVA antigen. Ultimately, astragalin encum-
bered the induction of EMT and fibrosis under the milieu
of oxidative stress and autophagic injury in mouse airways.
Therefore, astragalin was effective in ameliorating
oxidative stress-associated pulmonary fibrosis through
disturbing airway EMTand epithelial autophagic stress.
Competing interests
The authors (I-H. Cho, Y-J. Choi, J-H. Gong, D. Shin, M-K. Kang and Y-H. Kang)
declare that they have no competing interests.
Authors’ contributions
IHC, JHG and YHK designed research; IHC, JHG and DS conducted research;
IHC, JHG and MKK analyzed data; IHC, YJC and YHK wrote the paper; YHK
had primary responsibility for final content. All authors read and approved
the final manuscript.
Acknowledgements
This study was supported by National Research Foundation of Korea
(2012012946) and by the Ministry of Education, Science Technology and
National Research Foundation of Korea through the Human Resource
Training Project for Regional Innovation (2012-01-A-05-003-12-010100).
Received: 5 December 2014 Accepted: 10 April 2015
References
1. Li Y, Zhang J, Chen X, Liu T, He W, Chen Y. Molecular machinery of
autophagy and its implication in cancer. Am J Med Sci. 2012;343:155–61.
2. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N
Engl J Med. 2013;368:651–62.3. Huang J, Lam GY, Brumell JH. Autophagy signaling through reactive oxygen
species. Antioxid Redox Signal. 2011;14:2215–31.
4. Fung TS, Liu DX. Coronavirus infection, ER stress, apoptosis and innate
immunity. Front Microbiol. 2014;5:296.
5. Navarro-Yepes J, Burns M, Anandhan A, Khalimonchuk O, del Razo LM,
Quintanilla-Vega B, et al. Oxidative stress, redox signaling, and autophagy:
cell death versus survival. Antioxid Redox Signal. 2014;21:66–85.
6. Ryter SW, Cloonan SM, Choi AM. Autophagy: a critical regulator of cellular
metabolism and homeostasis. Mol Cells. 2013;36:7–16.
7. Kongara S, Karantza V. The interplay between autophagy and ROS in
tumorigenesis. Front Oncol. 2012;2:171.
8. Zuo L, Otenbaker NP, Rose BA, Salisbury KS. Molecular mechanisms of
reactive oxygen species-related pulmonary inflammation and asthma.
Mol Immunol. 2013;56:57–63.
9. Lee IT, Yang CM. Role of NADPH oxidase/ROS in pro-inflammatory
mediators-induced airway and pulmonary diseases. Biochem Pharmacol.
2012;84:581–90.
10. Poon A, Eidelman D, Laprise C, Hamid Q. ATG5, autophagy and lung
function in asthma. Autophagy. 2012;8:694–5.
11. Araya J, Hara H, Kuwano K. Autophagy in the pathogenesis of pulmonary
disease. Intern Med. 2013;52:2295–303.
12. Malaviya R, Laskin JD, Laskin DL. Oxidative stress-induced autophagy: role in
pulmonary toxicity. Toxicol Appl Pharmacol. 2014;275:145–51.
13. Ding Y, Choi ME. Regulation of autophagy by TGF-β: emerging role in
kidney fibrosis. Semin Nephrol. 2014;34:62–71.
14. Ricci A, Cherubini E, Scozzi D, Pietrangeli V, Tabbì L, Raffa S, et al. Decreased
expression of autophagic beclin 1 protein in idiopathic pulmonary fibrosis
fibroblasts. J Cell Physiol. 2013;228:1516–24.
15. Araya J, Kojima J, Takasaka N, Ito S, Fujii S, Hara H, et al. Insufficient
autophagy in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol
Physiol. 2013;304:L56–69.
16. Li F, Liang D, Yang Z, Wang T, Wang W, Song X, et al. Astragalin suppresses
inflammatory responses via down-regulation of NF-κB signaling pathway in
lipopolysaccharide-induced mastitis in a murine model. Int Immunopharmacol.
2013;17:478–82.
17. Soromou LW, Chen N, Jiang L, Huo M, Wei M, Chu X, et al. Astragalin
attenuates lipopolysaccharide-induced inflammatory responses by
down-regulating NF-κB signaling pathway. Biochem Biophys Res
Commun. 2012;419:256–61.
18. Cho IH, Gong JH, Kang MK, Lee EJ, Park JH, Park SJ, et al. Astragalin
inhibits airway eotaxin-1 induction and epithelial apoptosis through
modulating oxidative stress-responsive MAPK signaling. BMC Pulm Med.
2014;14:122.
19. Ponnusamy MP, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Batra SK.
Emerging role of mucins in epithelial to mesenchymal transition. Curr
Cancer Drug Targets. 2013;13:945–56.
20. Yamauchi K, Inoue H. Airway remodeling in asthma and irreversible airflow
limitation-ECM deposition in airway and possible therapy for remodeling.
Allergol Int. 2007;56:321–9.
21. Macintosh RL, Ryan KM. Autophagy in tumour cell death. Semin Cancer Biol.
2013;23:344–51.
22. Jiang L, Diaz PT, Best TM, Stimpfl JN, He F, Zuo L. Molecular characterization
of redox mechanisms in allergic asthma. Ann Allergy Asthma Immunol.
2014;113:137–42.
23. Hoffman SM, Tully JE, Nolin JD, Lahue KG, Goldman DH, Daphtary N, et al.
Endoplasmic reticulum stress mediates house dust mite-induced airway
epithelial apoptosis and fibrosis. Respir Res. 2013;14:141.
24. Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as
a therapeutic strategy. Pharmacol Ther. 2006;111:476–94.
25. Bowler RP. Oxidative stress in the pathogenesis of asthma. Curr Allergy
Asthma Rep. 2004;4:116–22.
26. Cheresh P, Kim SJ, Tulasiram S, Kamp DW. Oxidative stress and pulmonary
fibrosis. Biochim Biophys Acta. 1832;2013:1028–40.
27. Camelo A, Dunmore R, Sleeman MA, Clarke DL. The epithelium in idiopathic
pulmonary fibrosis: breaking the barrier. Front Pharmacol. 2014;4:173.
28. Inghilleri S, Morbini P, Campo I, Zorzetto M, Oggionni T, Pozzi E, et al.
Factors influencing oxidative imbalance in pulmonary fibrosis: an
immunohistochemical study. Pulm Med. 2011;2011:421409.
29. Felton VM, Borok Z, Willis BC. N-acetylcysteine inhibits alveolar epithelial-
mesenchymal transition. Am J Physiol Lung Cell Mol Physiol.
2009;297:L805–12.
Cho et al. Respiratory Research  (2015) 16:51 Page 13 of 1330. Hernández-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, Yue Z,
et al. Autophagy releases lipid that promotes fibrogenesis by activated
hepatic stellate cells in mice and in human tissues. Gastroenterology.
2012;142:938–46.
31. Patel AS, Lin L, Geyer A, Haspel JA, An CH, Cao J, et al. Autophagy in
idiopathic pulmonary fibrosis. PLoS One. 2012;7, e41394.
32. Lee KW, Thiyagarajan V, Sie HW, Cheng MF, Tsai MJ, Chia YC, et al. Synergistic
effect of natural compounds on the fatty acid-induced autophagy of activated
hepatic stellate cells. J Nutr Biochem. 2014;25:903–13.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
